Azbec 100 mcg/puff (Inhaler)

200 metered doses: ৳ 270.00

Medicine Details

Category	Details
Generic	Beclomethasone dipropionate inhaler
Company	Eskayef pharmaceuticals ltd
Also available as	Azbec 250 mcg inhaler

Prophylactic management of mild, moderate, or severe asthma in adults or children
Effective anti-inflammatory action in the lungs
Lower incidence and severity of adverse effects compared to systemic corticosteroids
Treatment for patients requiring symptomatic bronchodilator asthma medication
For patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone
For patients with severe chronic asthma
Reduction or elimination of requirement for oral corticosteroids
Effective preventative treatment for asthma

Produces anti-inflammatory and vasoconstrictor effects
Wide range of effects on multiple cell types and mediators involved in inflammation
Pro-drug with weak glucocorticoid receptor binding affinity
Hydrolyzed to active metabolite beclomethasone-17-monopropionate (B-17-MP)

For oral inhalation use only
Starting dose appropriate to severity of disease
Dose adjustment until control is achieved
Reduced to minimum effective dose according to individual response
Usual starting dose for adults is 200 micrograms twice a day
Higher starting dose for more severe cases
Total daily dose may be administered as two, three, or four divided doses
Starting dose for children is 50 to 100 micrograms two, three, or four times daily in accordance to the response
Alternatively, 100 micrograms or 200 micrograms twice daily for children
No need to increase the dose in patients with hepatic or renal impairment

Correct and regular use prevents or lessens the severity of asthma attacks
Instructions for effective use according to National Asthma Guidelines for Medical Practitioners
Recommendations for cleaning the inhaler at least once a week

Systemic effects of inhaled corticosteroids at high doses
Possible systemic effects include Cushing's syndrome, Cushingoid features, and adrenal suppression
Growth retardation in children and adolescents
Decrease in bone mineral density
Cataract and glaucoma

Inadequate evidence of safety in human pregnancy
Administration of corticosteroids to pregnant animals can cause abnormalities of fetal development
Therapeutic benefits versus potential hazards to the mother and baby

Proper use of the inhaler and regular use for optimum benefit
Patients should be instructed in the proper use of the inhaler and have their technique checked to ensure drug reaches target areas within the lungs